The synthesis of conolidine, a scarce, naturally occurring compound, has enabled the first studies of its pharmacological properties to be carried out. Excitingly, conolidine is a painkiller that seems to have an unusual mechanism of action.
This is a preview of subscription content, access via your institution
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Get just this article for as long as you need it
Prices may be subject to local taxes which are calculated during checkout
Tarselli, M. A. et al. Nature Chem. 3, 449–453 (2011).
Kam, T.-S., Pang, H.-S., Choo, Y.-M. & Komiyama, K. Chem. Biodiver. 1, 646–656 (2004).
Potier, P. & Janot, M. M. C.R. Acad. Sci. 276C, 1727 (1973).
Scott, A. I., Yeh, C.-L. & Greenslade, D. J. Chem. Soc. Chem. Commun. 947–948 (1978).
Rice, K. C. in The Chemistry and Biology of Isoquinoline Alkaloids (eds Phillipson, J. D., Roberts, M. F. & Zenk, M. H.) 191–203 (Springer, 1985).
Rights and permissions
About this article
Cite this article
Reisman, S. New lead for pain treatment. Nature 473, 458–459 (2011). https://doi.org/10.1038/473458a